Cargando…

Analysis of the rate of force development reveals high neuromuscular fatigability in elderly patients with chronic kidney disease

BACKGROUND: Chronic kidney disease (CKD) induces muscle wasting and a reduction in the maximum voluntary force (MVF). Little is known about the neuromuscular fatigability in CKD patients, defined as the reduction of muscle force capacities during exercise. Neuromuscular fatigability is a crucial phy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatrenet, Antoine, Piccoli, Giorgina, Audebrand, Jean Michel, Torreggiani, Massimo, Barbieux, Julien, Vaillant, Charly, Morel, Baptiste, Durand, Sylvain, Beaune, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570076/
https://www.ncbi.nlm.nih.gov/pubmed/37439126
http://dx.doi.org/10.1002/jcsm.13280
_version_ 1785119684392124416
author Chatrenet, Antoine
Piccoli, Giorgina
Audebrand, Jean Michel
Torreggiani, Massimo
Barbieux, Julien
Vaillant, Charly
Morel, Baptiste
Durand, Sylvain
Beaune, Bruno
author_facet Chatrenet, Antoine
Piccoli, Giorgina
Audebrand, Jean Michel
Torreggiani, Massimo
Barbieux, Julien
Vaillant, Charly
Morel, Baptiste
Durand, Sylvain
Beaune, Bruno
author_sort Chatrenet, Antoine
collection PubMed
description BACKGROUND: Chronic kidney disease (CKD) induces muscle wasting and a reduction in the maximum voluntary force (MVF). Little is known about the neuromuscular fatigability in CKD patients, defined as the reduction of muscle force capacities during exercise. Neuromuscular fatigability is a crucial physical parameter of the daily living. The quantification of explosive force has been shown to be a sensitive means to assess neuromuscular fatigability. Thus, our study used explosive force estimates to assess neuromuscular fatigability in elderly CKD patients. METHODS: Inclusion criteria for CKD patients were age ≥ 60 years old and glomerular filtration rate (GFR) < 45 mL/min/1.73 m(2) not on dialysis, and those for controls were GFR > 60 mL/min/1.73 m(2), age and diabetes matched. The fatigability protocol focused on a handgrip task coupled with surface electromyography (sEMG). Scalars were extracted from the rate of force development (RFD): absolute and normalized time periods (50, 75, 100, 150 and 200 ms, RFD(50), RFD(75), RFD(100), RFD(150) and RFD(200), respectively), peak RFD (RFD(peak) in absolute; NRFD(peak) normalized), time‐to‐peak RFD (t‐RFD(peak)) and the relative force at RFD(peak) (MVF‐RFD(peak)). A statistical parametric mapping approach was performed on the force, impulse and RFD–time curves. The integrated sEMG with time at 0–30, 0–50, 0–100 and 0–200 ms time intervals relative to onset of sEMG activity was extracted and groups were compared separately for each sex. RESULTS: The cohort of 159 individuals had a median age of 69 (9(IQR)) years and body mass index was 27.6 (6.2(IQR)) kg/m(2). Propensity‐score‐matched groups balanced CKD patients and controls by gender with 66 males and 34 females. In scalar analysis, CKD patients manifested a higher decrement than controls in the early phase of contraction, regarding the NRFD(peak) (P = 0.009; η(2) (p) = 0.034) and RFD(75) and RFD(100) (for both P < 0.001; η(2) (p) = 0.068 and 0.064). The one‐dimensional analysis confirmed that CKD males manifest higher and delayed neuromuscular fatigability, especially before 100 ms from onset of contraction. sEMG was lower in CKD patients than controls in the 0–100 ms (at rest: P = 0.049, Cohen's d = 0.458) and 0–200 ms (at rest: P = 0.016, Cohen's d = 0.496; during exercise: P = 0.006, Cohen's d = 0.421) time windows. Controls showed greater decrease of sEMG than CKD patients in the 0–30 ms (P = 0.020, Cohen's d = 0.533) and 0–50 ms (P = 0.010, Cohen's d = 0.640) time windows. As opposite to females, males showed almost the same differences between groups. CONCLUSIONS: Our study is the first to show that CKD patients have higher fatigability than controls, which may be associated with an impaired motor‐unit recruitment, highlighting a neural drive disturbance with CKD. Further studies are needed to confirm these findings.
format Online
Article
Text
id pubmed-10570076
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105700762023-10-14 Analysis of the rate of force development reveals high neuromuscular fatigability in elderly patients with chronic kidney disease Chatrenet, Antoine Piccoli, Giorgina Audebrand, Jean Michel Torreggiani, Massimo Barbieux, Julien Vaillant, Charly Morel, Baptiste Durand, Sylvain Beaune, Bruno J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: Chronic kidney disease (CKD) induces muscle wasting and a reduction in the maximum voluntary force (MVF). Little is known about the neuromuscular fatigability in CKD patients, defined as the reduction of muscle force capacities during exercise. Neuromuscular fatigability is a crucial physical parameter of the daily living. The quantification of explosive force has been shown to be a sensitive means to assess neuromuscular fatigability. Thus, our study used explosive force estimates to assess neuromuscular fatigability in elderly CKD patients. METHODS: Inclusion criteria for CKD patients were age ≥ 60 years old and glomerular filtration rate (GFR) < 45 mL/min/1.73 m(2) not on dialysis, and those for controls were GFR > 60 mL/min/1.73 m(2), age and diabetes matched. The fatigability protocol focused on a handgrip task coupled with surface electromyography (sEMG). Scalars were extracted from the rate of force development (RFD): absolute and normalized time periods (50, 75, 100, 150 and 200 ms, RFD(50), RFD(75), RFD(100), RFD(150) and RFD(200), respectively), peak RFD (RFD(peak) in absolute; NRFD(peak) normalized), time‐to‐peak RFD (t‐RFD(peak)) and the relative force at RFD(peak) (MVF‐RFD(peak)). A statistical parametric mapping approach was performed on the force, impulse and RFD–time curves. The integrated sEMG with time at 0–30, 0–50, 0–100 and 0–200 ms time intervals relative to onset of sEMG activity was extracted and groups were compared separately for each sex. RESULTS: The cohort of 159 individuals had a median age of 69 (9(IQR)) years and body mass index was 27.6 (6.2(IQR)) kg/m(2). Propensity‐score‐matched groups balanced CKD patients and controls by gender with 66 males and 34 females. In scalar analysis, CKD patients manifested a higher decrement than controls in the early phase of contraction, regarding the NRFD(peak) (P = 0.009; η(2) (p) = 0.034) and RFD(75) and RFD(100) (for both P < 0.001; η(2) (p) = 0.068 and 0.064). The one‐dimensional analysis confirmed that CKD males manifest higher and delayed neuromuscular fatigability, especially before 100 ms from onset of contraction. sEMG was lower in CKD patients than controls in the 0–100 ms (at rest: P = 0.049, Cohen's d = 0.458) and 0–200 ms (at rest: P = 0.016, Cohen's d = 0.496; during exercise: P = 0.006, Cohen's d = 0.421) time windows. Controls showed greater decrease of sEMG than CKD patients in the 0–30 ms (P = 0.020, Cohen's d = 0.533) and 0–50 ms (P = 0.010, Cohen's d = 0.640) time windows. As opposite to females, males showed almost the same differences between groups. CONCLUSIONS: Our study is the first to show that CKD patients have higher fatigability than controls, which may be associated with an impaired motor‐unit recruitment, highlighting a neural drive disturbance with CKD. Further studies are needed to confirm these findings. John Wiley and Sons Inc. 2023-07-13 /pmc/articles/PMC10570076/ /pubmed/37439126 http://dx.doi.org/10.1002/jcsm.13280 Text en © 2023 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Chatrenet, Antoine
Piccoli, Giorgina
Audebrand, Jean Michel
Torreggiani, Massimo
Barbieux, Julien
Vaillant, Charly
Morel, Baptiste
Durand, Sylvain
Beaune, Bruno
Analysis of the rate of force development reveals high neuromuscular fatigability in elderly patients with chronic kidney disease
title Analysis of the rate of force development reveals high neuromuscular fatigability in elderly patients with chronic kidney disease
title_full Analysis of the rate of force development reveals high neuromuscular fatigability in elderly patients with chronic kidney disease
title_fullStr Analysis of the rate of force development reveals high neuromuscular fatigability in elderly patients with chronic kidney disease
title_full_unstemmed Analysis of the rate of force development reveals high neuromuscular fatigability in elderly patients with chronic kidney disease
title_short Analysis of the rate of force development reveals high neuromuscular fatigability in elderly patients with chronic kidney disease
title_sort analysis of the rate of force development reveals high neuromuscular fatigability in elderly patients with chronic kidney disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570076/
https://www.ncbi.nlm.nih.gov/pubmed/37439126
http://dx.doi.org/10.1002/jcsm.13280
work_keys_str_mv AT chatrenetantoine analysisoftherateofforcedevelopmentrevealshighneuromuscularfatigabilityinelderlypatientswithchronickidneydisease
AT piccoligiorgina analysisoftherateofforcedevelopmentrevealshighneuromuscularfatigabilityinelderlypatientswithchronickidneydisease
AT audebrandjeanmichel analysisoftherateofforcedevelopmentrevealshighneuromuscularfatigabilityinelderlypatientswithchronickidneydisease
AT torreggianimassimo analysisoftherateofforcedevelopmentrevealshighneuromuscularfatigabilityinelderlypatientswithchronickidneydisease
AT barbieuxjulien analysisoftherateofforcedevelopmentrevealshighneuromuscularfatigabilityinelderlypatientswithchronickidneydisease
AT vaillantcharly analysisoftherateofforcedevelopmentrevealshighneuromuscularfatigabilityinelderlypatientswithchronickidneydisease
AT morelbaptiste analysisoftherateofforcedevelopmentrevealshighneuromuscularfatigabilityinelderlypatientswithchronickidneydisease
AT durandsylvain analysisoftherateofforcedevelopmentrevealshighneuromuscularfatigabilityinelderlypatientswithchronickidneydisease
AT beaunebruno analysisoftherateofforcedevelopmentrevealshighneuromuscularfatigabilityinelderlypatientswithchronickidneydisease